Semnur (SMNR) Form 3: Director Navani Annu Reports No Ownership

Navani Annu, listed at a Palo Alto address and identified as a director of Semnur Pharmaceuticals, Inc. (SMNR), filed an initial Form 3 reporting no securities beneficially owned.

Rhea-AI Filing Summary

Navani Annu, listed at a Palo Alto address and identified as a director of Semnur Pharmaceuticals, Inc. (SMNR), filed an initial Form 3 reporting no securities beneficially owned. The filing is signed by an attorney-in-fact and references Exhibit 24 (Power of Attorney). The statement indicates this is an individual filing by one reporting person and records the event date as 09/22/2025.

Insights

Corporate Governance Expert

TL;DR: Initial director filing reports no beneficial ownership, signaling no immediate insider share exposure.

The Form 3 documents a director-level reporting person who, at the time of the required disclosure event, does not beneficially own any shares or derivative positions in Semnur Pharmaceuticals, Inc. This is a routine disclosure required under Section 16. The inclusion of Exhibit 24 indicates a Power of Attorney was used to file the form on the reporting person's behalf.

Securities Compliance Analyst

TL;DR: Compliance filing is procedural and neutral; no securities held reduces potential Section 16 reporting triggers.

The Form 3 appears complete for its purpose: identifying the reporting person, relationship to the issuer as a director, and stating that no securities are beneficially owned. Because no positions are reported, there are no immediate Section 16(b) short-swing profit implications. The signature by an attorney-in-fact and reference to a Power of Attorney are procedural details relevant to filing authority.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who filed the Form 3 for Semnur Pharmaceuticals (SMNR)?

The Form 3 was filed for Navani Annu, who is identified as a director of Semnur Pharmaceuticals, Inc.

Does the Form 3 report any securities owned by the reporting person for SMNR?

No. The filing explicitly states no securities are beneficially owned by the reporting person.

What is the date of the event requiring the Form 3 filing?

The date of the event requiring the statement is 09/22/2025.

Was the Form 3 filed by more than one reporting person?

No. The form indicates it was filed by one reporting person.

Is there any power of attorney noted on the Form 3?

Yes. The filing references Exhibit 24 - Power of Attorney and is signed by an attorney-in-fact.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/26/2025 - 04:10 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Navani Annu

(Last) (First) (Middle)

C/O SEMNUR PHARMACEUTICALS, INC.

960 SAN ANTONIO ROAD

(Street)

PALO ALTO CA 94303

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
09/22/2025

3. Issuer Name and Ticker or Trading Symbol
Semnur Pharmaceuticals, Inc. [ SMNR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney.

No securities are beneficially owned.

	/s/ Stephen Ma, as attorney-in-fact	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.